Early research (Phase 1)Not Yet RecruitingNCT06990620What this trial is testingTACE Plus Ivonescimab for Unresectable Non-Metastatic HCCWho this might be right forHepatocellular Carcinoma (HCC) Fudan University 56
Not applicableEnded earlyNCT02917759What this trial is testingLiver and Biliary Tumor Tissue RegistryWho this might be right forHepatocellular CarcinomaCholangiocarcinoma Mayo Clinic 1,000
Not applicableLooking for participantsNCT05828446What this trial is testingImproving Hepatocellular Carcinoma ScreeningWho this might be right forMagnetic Resonance ImagingHepatocellular CarcinomaScreening+1 more Naik Vietti Violi 330
Not applicableLooking for participantsNCT06658782What this trial is testingAbbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver CancerWho this might be right forCirrhosisCirrhosis Due to Hepatitis BCirrhosis and Chronic Liver Disease+3 more University of Oxford 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06041490What this trial is testingAdjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver TransplantationWho this might be right forLiver Transplant; ComplicationsHepatocarcinomaRecurrent Osteosarcoma+1 more Peking Union Medical College Hospital 88
Not applicableUnknownNCT02501980What this trial is testingHepatocellular Cancer (HCC) Screening in Zhongshan CityWho this might be right forLiver Neoplasms Zhongshan People's Hospital, Guangdong, China 20,000
Large-scale testing (Phase 3)Study completedNCT00814242What this trial is testingHepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood VesselsWho this might be right forHepatocellular Carcinoma Eastern Hepatobiliary Surgery Hospital 120
Large-scale testing (Phase 3)UnknownNCT01747642What this trial is testingSafety and Efficacy of Oncoxin Plus Surafineb in Hepatocellular CarcinomaWho this might be right forQuality of Life Clinical Research Organization, Dhaka, Bangladesh 60
Not applicableLooking for participantsNCT06960954What this trial is testingPIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular CarcinomaWho this might be right forHepato Cellular Carcinoma (HCC)Portal Vein Tumour Thrombosis Tanta University 116
Testing effectiveness (Phase 2)Study completedNCT04954794What this trial is testingTACE Combined with Sintilimab Plus Bevacizumab Biosimilar in Patients with Advanced Hepatocellular Carcinoma (TASK-02)Who this might be right forHepatocellular Carcinoma Fudan University 29
Early research (Phase 1)Ended earlyNCT04502082What this trial is testingStudy of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)Who this might be right forHepatocellular CarcinomaLiver CancerLiver Neoplasm+1 more Eureka Therapeutics Inc. 8
Large-scale testing (Phase 3)Looking for participantsNCT06796803What this trial is testingCamrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC)Who this might be right forPotentially Resectable Hepatocellular Carcinoma Shanghai Zhongshan Hospital 398
Not applicableStudy completedNCT07483242What this trial is testingIndividualized Surgical Guidance in HCC-BDTTWho this might be right forHepatocellular Carcinoma (HCC) First Affiliated Hospital, Sun Yat-Sen University 151
Early research (Phase 1)Temporarily pausedNCT04506983What this trial is testingGPC3-CAR-T Cells for the Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Beijing Tsinghua Chang Gung Hospital 12
Post-approval studies (Phase 4)UnknownNCT06003673What this trial is testingA Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCCWho this might be right forHepatocellular Carcinoma Resectable First Affiliated Hospital of Fujian Medical University 20
Testing effectiveness (Phase 2)Ended earlyNCT00319683What this trial is testingADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Adherex Technologies, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06880523What this trial is testingSTRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Canadian Cancer Trials Group 140
Not applicableStudy completedNCT03163186What this trial is testingTransradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial).Who this might be right forHepatic CarcinomaChemoembolizatonTransarterial Embolization Medical University of South Carolina 55
Early research (Phase 1)Study completedNCT02151864What this trial is testingLDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 CirrhosisWho this might be right forHepatocellular CarcinomaCirrhosis Jason K. Sicklick, M.D. 9
Large-scale testing (Phase 3)Study completedNCT02774187What this trial is testingSorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCCWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 247